Biomarkers in Kidney Disease

A biomarker is a substance introduced into an organism to assess organ function or various aspects of health. For instance, rubidium chloride is employed in isotopic labeling to assess the perfusion of the heart muscle. Alternatively, it can be a substance whose detection indicates a specific disease state; for example, the presence of an antibody may signify an infection. More specifically, a biomarker indicates a change in the expression or condition of a protein that is associated with the risk or progression of a disease, or the responsiveness of the disease to a given treatment. Biomarkers can be distinctive biological properties or molecules detectable and measurable in body parts such as blood or tissue. They may signify either normal or diseased processes in the body. Biomarkers can include specific cells, molecules, or genes, gene products, chemicals, or hormones. Complex organ functions or overall characteristic changes in biological systems can also serve as biomarkers.


    Related Conference of Biomarkers in Kidney Disease

    June 13-14, 2024

    9th World Kidney Congress

    Barcelona, Spain
    July 25-26, 2024

    28th European Nephrology Conference

    Frankfurt, Germany
    October 03-04, 2024

    22nd International Conference on Nephrology, Urology and Therapeutics

    Singapore City, Singapore

    Biomarkers in Kidney Disease Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in